CHARLOTTE, N.C. - Wednesday, October 2nd 2013 [ME NewsWire]
(BUSINESS WIRE)-- Bank of America announced today that it has completed the merger of its Merrill Lynch & Co., Inc. subsidiary into Bank of America Corp. Bank of America previously stated that it was considering merging Merrill Lynch & Co., Inc. directly into Bank of America Corp. as early as the fourth quarter of 2013. The merger has no effect on the Merrill Lynch name and brand, and will have no impact on customers or clients.
Subsidiaries of Merrill Lynch & Co., Inc., a holding company, will continue to operate under the Merrill Lynch name and brand. Bank of America’s primary broker-dealer, Merrill Lynch, Pierce, Fenner & Smith, and its non-U.S. broker-dealer entities will continue to operate under their current names and brands.
As of Oct. 1, in connection with the merger, Bank of America Corp. assumed all of Merrill Lynch & Co., Inc.’s obligations, including its outstanding U.S. and non-U.S. debt securities, its obligations regarding outstanding trust-preferred securities, and its guarantees of both outstanding non-U.S. debt securities issued by its subsidiaries and trading contracts of its subsidiaries. Also, as a result of the merger, Merrill Lynch & Co., Inc. will cease to separately file reports with the U.S. Securities and Exchange Commission.
Bank of America Bank of America is one of the world's largest financial institutions, serving individual consumers, small- and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. We serve approximately 51 million consumer and small business relationships with approximately 5,300 retail banking offices and approximately 16,350 ATMs and award-winning online banking with 30 million active users and more than 13 million mobile users. Bank of America is among the world's leading wealth management companies and is a global leader in corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to approximately 3 million small business owners through a suite of innovative, easy-to-use online products and services. The company serves clients through operations in more than 40 countries. Bank of America Corporation stock (NYSE: BAC) is listed on the New York Stock Exchange.
Visit the Bank of America newsroom for more Bank of America news.
www.bankofamerica.com
Contacts
Reporters May Contact:
Jerry Dubrowski, Bank of America, 1.980.388.2840
jerome.f.dubrowski@bankofamerica.com
Investors May Contact:
Jonathan Blum, Bank of America, 1.212.449.3112
jonathan.blum@bankofamerica.com
Permalink: http://www.me-newswire.net/news/8686/en
Thursday, October 3, 2013
Wednesday, October 2, 2013
Citi Launches e for Education
Global Philanthropic Initiative Will Leverage Citi Velocity Platform
ME Newswire / Business Wire
NEW YORK - Tuesday, October 1st 2013
Citi today announced the launch of e for Education, a three-month initiative to raise funds for education-related nonprofits around the world. Beginning today and through December 31, Citi will donate funds to several charities based on a percentage of institutional client FX transaction volumes executed through its electronic trading platform, Velocity.
Citi Velocity is an award-winning proprietary FX electronic trading platform for institutional clients. It provides real-time pricing with one-click trading for multiple foreign exchange products, including spot, forwards, swaps and options. Citi Velocity is used by a large number of Citi’s institutional clients globally not only for trading but also as their source for research, economics, FX market color and post-trade activity.
“We believe e for Education is the first and certainly the largest effort by a firm seeking to translate its electronic FX trading activity into philanthropic dollars,” said Jeff Feig, Citi’s Global Head of G-10 FX. “Citi believes that access to quality education is the key to unlocking a lifetime of opportunity and we are excited to launch an initiative that will benefit youth around the world.”
Six organizations, spanning a range of geographies and core focus areas, were selected to benefit from the e for Education initiative. Funds will be donated to each organization based on the geographic location of individual Citi Velocity clients, although users can also override the default and earmark their corresponding donation to any e for Education organization of their choosing. The e for Education beneficiaries include:
Civic Builders (North America) Civic Builders partners with the nation’s best educators to build state-of-the-art, low-cost charter schools for children and families in underserved neighborhoods.
EMpower (Eastern Europe, Asia Pacific, Latin America, and Africa) supports local organizations in emerging markets countries that provide at-risk youth with the tools and resources they need to lead healthy, productive lives.
No Greater Sacrifice (North America) is dedicated to the children of fallen and wounded U.S. military service members by delivering scholarships and resources to improve their quality of life through the pursuit of higher education.
Room to Read (Asia/Africa) seeks to transform the lives of millions of children in the developing world by focusing on literacy and gender equality in education.
Teach First (United Kingdom) works towards a day when no child’s educational success is limited by their socio-economic background.
Uncommon Schools (North America) starts and manages outstanding urban public charter schools that close the achievement gap and prepare low-income students to graduate from college.
Citi, one of the largest FX providers in the world, is not setting specific fundraising goals, but has also not imposed a cap on the maximum amount that may be donated. Total donations will be driven purely by client FX transaction volumes.
“Citi has a long history of supporting educational ambitions, whether it’s through our businesses or through the work of the Citi Foundation,” said Bapi Maitra, Citi’s Global Head of Institutional e-Commerce Sales. “The e for Education initiative builds on Citi’s track record of connecting students around the world to educational opportunities and support services that empower them to improve their lives.”
About Citi
Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.
Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://blog.citigroup.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi
Contacts
Media:
Scott Helfman (FX), 212-816-9241
scott.helfman@citi.com
David Roskin (Corporate Citizenship), 212-559-4767
david.roskin@citi.com
Permalink: http://me-newswire.net/news/8675/en
ME Newswire / Business Wire
NEW YORK - Tuesday, October 1st 2013
Citi today announced the launch of e for Education, a three-month initiative to raise funds for education-related nonprofits around the world. Beginning today and through December 31, Citi will donate funds to several charities based on a percentage of institutional client FX transaction volumes executed through its electronic trading platform, Velocity.
Citi Velocity is an award-winning proprietary FX electronic trading platform for institutional clients. It provides real-time pricing with one-click trading for multiple foreign exchange products, including spot, forwards, swaps and options. Citi Velocity is used by a large number of Citi’s institutional clients globally not only for trading but also as their source for research, economics, FX market color and post-trade activity.
“We believe e for Education is the first and certainly the largest effort by a firm seeking to translate its electronic FX trading activity into philanthropic dollars,” said Jeff Feig, Citi’s Global Head of G-10 FX. “Citi believes that access to quality education is the key to unlocking a lifetime of opportunity and we are excited to launch an initiative that will benefit youth around the world.”
Six organizations, spanning a range of geographies and core focus areas, were selected to benefit from the e for Education initiative. Funds will be donated to each organization based on the geographic location of individual Citi Velocity clients, although users can also override the default and earmark their corresponding donation to any e for Education organization of their choosing. The e for Education beneficiaries include:
Civic Builders (North America) Civic Builders partners with the nation’s best educators to build state-of-the-art, low-cost charter schools for children and families in underserved neighborhoods.
EMpower (Eastern Europe, Asia Pacific, Latin America, and Africa) supports local organizations in emerging markets countries that provide at-risk youth with the tools and resources they need to lead healthy, productive lives.
No Greater Sacrifice (North America) is dedicated to the children of fallen and wounded U.S. military service members by delivering scholarships and resources to improve their quality of life through the pursuit of higher education.
Room to Read (Asia/Africa) seeks to transform the lives of millions of children in the developing world by focusing on literacy and gender equality in education.
Teach First (United Kingdom) works towards a day when no child’s educational success is limited by their socio-economic background.
Uncommon Schools (North America) starts and manages outstanding urban public charter schools that close the achievement gap and prepare low-income students to graduate from college.
Citi, one of the largest FX providers in the world, is not setting specific fundraising goals, but has also not imposed a cap on the maximum amount that may be donated. Total donations will be driven purely by client FX transaction volumes.
“Citi has a long history of supporting educational ambitions, whether it’s through our businesses or through the work of the Citi Foundation,” said Bapi Maitra, Citi’s Global Head of Institutional e-Commerce Sales. “The e for Education initiative builds on Citi’s track record of connecting students around the world to educational opportunities and support services that empower them to improve their lives.”
About Citi
Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.
Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://blog.citigroup.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi
Contacts
Media:
Scott Helfman (FX), 212-816-9241
scott.helfman@citi.com
David Roskin (Corporate Citizenship), 212-559-4767
david.roskin@citi.com
Permalink: http://me-newswire.net/news/8675/en
Boehringer Ingelheim to Announce Pivotal Phase III Hepatitis C Data for Faldaprevir* at AASLD Congress 2013
INGELHEIM, Germany - Tuesday, October 1st 2013 [ME NewsWire]
(BUSINESS WIRE) For media outside of the U.S.A., UK and Canada only
Ten abstracts featuring Boehringer Ingelheim’s investigational hepatitis C virus (HCV) protease inhibitor, faldaprevir*and polymerase inhibitor, deleobuvir* will be presented at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) 2013, 1-5 November, Washington.1
Faldaprevir* is a second generation protease inhibitor and is the foundation of Boehringer Ingelheim’s interferon-based and interferon-free treatment regimens.
The accepted abstracts include final results from the Phase III STARTVerso™1 and 2 studies, investigating the treatment regimen of faldaprevir* in combination with pegylated interferon and ribavirin. Also data in difficult-to-treat populations such as treatment-experienced (STARTVerso™3 – final data) and HCV/HIV co-infected (STARTVerso™4 – end of treatment data) patients will be presented at the meeting, adding to the comprehensive portfolio of data for faldaprevir in HCV. The STARTVerso™ trial results form the basis for regulatory submissions of faldaprevir.
Boehringer Ingelheim’s comprehensive hepatitis C clinical trial programme includes a broad range of the type of patients that clinicians see every day in clinical practice. The company’s goal is to develop effective and well tolerated treatments recognising the unmet need for more patient centric approaches in hepatitis C.
Boehringer Ingelheim’s abstracts can be accessed on the AASLD website today at www.aasld.org. Details of the poster presentations can be found below.
Poster Presentations
Title
Lead Author
Presentation Details
Effect of multiple oral doses of faldaprevir on the multiple dose pharmacokinetics of a combination oral tablet of ethinylestradiol and levonorgestrel in healthy premenopausal female volunteers
J. Sabo
ID# 482 Session: HCV Therapy: The Developmental Pipeline Date: Sat, 2 November Time: 2:00 PM – 7:30 PM ET Location: Poster Hall
Mass balance, metabolic profile and the role of hepatic and bacterial enzymes in the metabolism of the HCV polymerase inhibitor, deleobuvir (BI 207127)
R. Sane
ID# 491 Session: HCV Therapy: The Developmental Pipeline Date: Sat, 2 November Time: 2:00 PM – 7:30 PM ET Location: Poster Hall
Pharmacokinetics, safety, and tolerability of faldaprevir in patients with different levels of renal impairment
F. Huang
ID# 466 Session: HCV Therapy: The Developmental Pipeline Date: Sat, 2 November Time: 2:00 PM – 7:30 PM ET Location: Poster Hall
Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine/naloxone in subjects on stable addiction management therapy
D. Joseph
ID# 483 Session: HCV Therapy: The Developmental Pipeline Date: Sat, 2 November Time: 2:00 PM – 7:30 PM ET Location: Poster Hall
A pooled analysis of two randomized, double-blind placebo- controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic hepatitis C genotype-1 infection
D. Jensen
ID# 1088 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
Subgroup analyses and baseline predictors of response with faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic hepatitis C genotype-1 infection: a pooled analysis of STARTVerso1 and 2
E.M. Yoshida
ID# 1114 Session: HCV Therapeutics: New Agents
Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
STARTVerso3: A randomized, double-blind, placebo-controlled Phase III trial of faldaprevir in combination with pegylated interferon alfa-2a and ribavirin in treatment-experienced patients with chronic hepatitis C genotype-1 infection
I. Jacobson
ID# 1100 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
Interferon-Free Treatment with Faldaprevir, Deleobuvir (BI 207127) and Ribavirin in SOUND-C3: 95% SVR12 in HCV- GT1b
J.F. Dufour
ID# 1102 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
Pharmacokinetic interactions of faldaprevir and deleobuvir (BI 207127) and their individual and combined effect on selected cytochrome P450 (CYP) probe substrates in genotype 1 hepatitis C infected patients
C. Cooper
ID# 1083 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
STARTVerso 4 Phase III trial of faldaprevir plus peg interferon alfa-2a and ribavirin (PR) in patients with HIV and HCV genotype 1 coinfection: end of treatment response
J. Rockstroh
ID# 1099 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
NOTES TO EDITORS
The Boehringer Ingelheim NewsHome: An innovative resource for journalists
The Boehringer Ingelheim hepatitis C www.NewsHome.com is the one-stop-shop for clear, concise and easy to understand information about hepatitis C for media.
Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.
Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.
In 2012, Boehringer Ingelheim achieved net sales of about 14.7 billion euro. R&D expenditure in the business area Prescription Medicines corresponds to 22.5% of its net sales.
For more information please visit www.boehringer-ingelheim.com
References
1American Association for the Study of Liver diseases (AASLD). The Liver Meeting® Abstract Central. http://aasld2013.abstractcentral.com/viewer
[Last accessed 1 October, 2013]
* Faldaprevir and deleobuvir (BI 207127) are investigational compounds and not yet approved. Their safety and efficacy have not yet been fully established.
Contacts
Boehringer Ingelheim
Reinhard Malin
Corporate Communications
Media + PR
Reinhard Malin
Tel: +49 (6132) 77-90815
Fax: +49 (6132) 77-6601
Email: press@boehringer-ingelheim.com
More information
www.boehringer-ingelheim.com
Permalink: http://www.me-newswire.net/news/8684/en
(BUSINESS WIRE) For media outside of the U.S.A., UK and Canada only
Ten abstracts featuring Boehringer Ingelheim’s investigational hepatitis C virus (HCV) protease inhibitor, faldaprevir*and polymerase inhibitor, deleobuvir* will be presented at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) 2013, 1-5 November, Washington.1
Faldaprevir* is a second generation protease inhibitor and is the foundation of Boehringer Ingelheim’s interferon-based and interferon-free treatment regimens.
The accepted abstracts include final results from the Phase III STARTVerso™1 and 2 studies, investigating the treatment regimen of faldaprevir* in combination with pegylated interferon and ribavirin. Also data in difficult-to-treat populations such as treatment-experienced (STARTVerso™3 – final data) and HCV/HIV co-infected (STARTVerso™4 – end of treatment data) patients will be presented at the meeting, adding to the comprehensive portfolio of data for faldaprevir in HCV. The STARTVerso™ trial results form the basis for regulatory submissions of faldaprevir.
Boehringer Ingelheim’s comprehensive hepatitis C clinical trial programme includes a broad range of the type of patients that clinicians see every day in clinical practice. The company’s goal is to develop effective and well tolerated treatments recognising the unmet need for more patient centric approaches in hepatitis C.
Boehringer Ingelheim’s abstracts can be accessed on the AASLD website today at www.aasld.org. Details of the poster presentations can be found below.
Poster Presentations
Title
Lead Author
Presentation Details
Effect of multiple oral doses of faldaprevir on the multiple dose pharmacokinetics of a combination oral tablet of ethinylestradiol and levonorgestrel in healthy premenopausal female volunteers
J. Sabo
ID# 482 Session: HCV Therapy: The Developmental Pipeline Date: Sat, 2 November Time: 2:00 PM – 7:30 PM ET Location: Poster Hall
Mass balance, metabolic profile and the role of hepatic and bacterial enzymes in the metabolism of the HCV polymerase inhibitor, deleobuvir (BI 207127)
R. Sane
ID# 491 Session: HCV Therapy: The Developmental Pipeline Date: Sat, 2 November Time: 2:00 PM – 7:30 PM ET Location: Poster Hall
Pharmacokinetics, safety, and tolerability of faldaprevir in patients with different levels of renal impairment
F. Huang
ID# 466 Session: HCV Therapy: The Developmental Pipeline Date: Sat, 2 November Time: 2:00 PM – 7:30 PM ET Location: Poster Hall
Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine/naloxone in subjects on stable addiction management therapy
D. Joseph
ID# 483 Session: HCV Therapy: The Developmental Pipeline Date: Sat, 2 November Time: 2:00 PM – 7:30 PM ET Location: Poster Hall
A pooled analysis of two randomized, double-blind placebo- controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic hepatitis C genotype-1 infection
D. Jensen
ID# 1088 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
Subgroup analyses and baseline predictors of response with faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic hepatitis C genotype-1 infection: a pooled analysis of STARTVerso1 and 2
E.M. Yoshida
ID# 1114 Session: HCV Therapeutics: New Agents
Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
STARTVerso3: A randomized, double-blind, placebo-controlled Phase III trial of faldaprevir in combination with pegylated interferon alfa-2a and ribavirin in treatment-experienced patients with chronic hepatitis C genotype-1 infection
I. Jacobson
ID# 1100 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
Interferon-Free Treatment with Faldaprevir, Deleobuvir (BI 207127) and Ribavirin in SOUND-C3: 95% SVR12 in HCV- GT1b
J.F. Dufour
ID# 1102 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
Pharmacokinetic interactions of faldaprevir and deleobuvir (BI 207127) and their individual and combined effect on selected cytochrome P450 (CYP) probe substrates in genotype 1 hepatitis C infected patients
C. Cooper
ID# 1083 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
STARTVerso 4 Phase III trial of faldaprevir plus peg interferon alfa-2a and ribavirin (PR) in patients with HIV and HCV genotype 1 coinfection: end of treatment response
J. Rockstroh
ID# 1099 Session: HCV Therapeutics: New Agents Date: Sun, 3 November Time: 8:00 AM – 5:30 PM ET Location: Poster Hall
NOTES TO EDITORS
The Boehringer Ingelheim NewsHome: An innovative resource for journalists
The Boehringer Ingelheim hepatitis C www.NewsHome.com is the one-stop-shop for clear, concise and easy to understand information about hepatitis C for media.
Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.
Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.
In 2012, Boehringer Ingelheim achieved net sales of about 14.7 billion euro. R&D expenditure in the business area Prescription Medicines corresponds to 22.5% of its net sales.
For more information please visit www.boehringer-ingelheim.com
References
1American Association for the Study of Liver diseases (AASLD). The Liver Meeting® Abstract Central. http://aasld2013.abstractcentral.com/viewer
[Last accessed 1 October, 2013]
* Faldaprevir and deleobuvir (BI 207127) are investigational compounds and not yet approved. Their safety and efficacy have not yet been fully established.
Contacts
Boehringer Ingelheim
Reinhard Malin
Corporate Communications
Media + PR
Reinhard Malin
Tel: +49 (6132) 77-90815
Fax: +49 (6132) 77-6601
Email: press@boehringer-ingelheim.com
More information
www.boehringer-ingelheim.com
Permalink: http://www.me-newswire.net/news/8684/en
Quintiles' Third Quarter 2013 Earnings Call Scheduled for Thursday, October 31st
ME NewsWire / BusinessWire
RESEARCH TRIANGLE PARK, N.C - Tuesday, October 1st 2013
RESEARCH TRIANGLE PARK, N.C. - Oct. 1, 2013
Quintiles Transnational Holdings Inc. (NYSE:Q) will release its financial results for the third quarter of 2013 on Thursday, October 31, 2013, before the market opens. An investor conference call will be held on Thursday, October 31, 2013 at 8:00 a.m. EDT.
The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call.
An archived edition of the conference call will be available online at www.quintiles.com/investors after 1:00 p.m. EDT on Thursday, October 31st.
About Quintiles
Quintiles (NYSE:Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Phil Bridges, 1-919-998-1653
Media Relations
phil.bridges@quintiles.com
Karl Deonanan, +1-919-998-2789
Investor Relations
InvestorRelations@quintiles.com
Permalink: http://www.me-newswire.net/news/8682/en
RESEARCH TRIANGLE PARK, N.C - Tuesday, October 1st 2013
RESEARCH TRIANGLE PARK, N.C. - Oct. 1, 2013
Quintiles Transnational Holdings Inc. (NYSE:Q) will release its financial results for the third quarter of 2013 on Thursday, October 31, 2013, before the market opens. An investor conference call will be held on Thursday, October 31, 2013 at 8:00 a.m. EDT.
The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call.
An archived edition of the conference call will be available online at www.quintiles.com/investors after 1:00 p.m. EDT on Thursday, October 31st.
About Quintiles
Quintiles (NYSE:Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Phil Bridges, 1-919-998-1653
Media Relations
phil.bridges@quintiles.com
Karl Deonanan, +1-919-998-2789
Investor Relations
InvestorRelations@quintiles.com
Permalink: http://www.me-newswire.net/news/8682/en
Increasing the focus on “human capital” may open the road to market access
Hay Group white paper, Transforming to succeed: Make market access a competitive advantage in the changing life sciences landscape, contends that people will be the Life Science industry’s most powerful agents of change
ME NewsWire/ Business Wire
PHILADELPHIA - Wednesday, October 2nd 2013
The Hay Group Global Life Sciences Practice has just released a proprietary white paper which asserts that a redoubled focus on “human capital”—how people are organized, managed and selected—can pay bigger dividends than usual for life sciences companies in today’s changing environment. Why? Partly because many of the usual avenues to success in the industry have been clogged or even cut off by circumstances ranging from the impact of the patent cliff to the new composition of the “market” and what it expects from the life sciences industry. But mainly because the “sea change” in the industry has destroyed the efficacy of the traditional business model. Companies that formerly operated in a very well known space have now been forced to enter uncharted waters.
In a series of releases to follow this white paper, Hay Group will introduce data from its various life sciences databases which expose issues that support the tremendous upside potential of a human capital focus—from a pattern of potentially innovation-stifling management “de-motivation” that is high to the “engagement gap” in R&D.
“With the industry needing a radical mindset change to cope with the new value-based, customer-focused environment, it can’t just resort to modest structural change and move the same bodies into the new boxes,” according to the Hay Group paper’s primary author, Ian Wilcox, Vice president and managing director, global life sciences.
“There are fewer and fewer skill sets and required competencies from “old pharma” that match the ones needed in “new pharma,“ Wilcox contends. What we are seeing now is that many companies have made progress in blowing up the old business model and even reorganizing their structures in service of a new strategy—but the people side has received less emphasis—and that’s what makes even routine, let alone radical change, succeed. Since in many areas of the business this will almost mean starting from scratch, those companies that get ahead of the human capital curve will have a distinct advantage over their competition.
View white paper and companion blog here—white paper includes commentary from William Looney, Editor of Pharmaceutical Executive; Dr. Tehseen Salimi, former vice president of global evidence and value development at Sanofi; and Thomas P. Ference, clinical professor of health policy and management at the Mailman School at Columbia University.
About Hay Group
Hay Group is a global management consulting firm that works with leaders to transform strategy into reality. We develop talent, organize people to be more effective and motivate them to perform at their best. Our focus is on making change happen and helping people and organizations realize their potential. Visit www.haygroup.com
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20131001007045/en/
Contacts
Hay Group
Doran Twer
Ph: +1-215-861-2337
C: +1-215-470-1800
doran.twer@haygroup.com
Permalink: http://www.me-newswire.net/news/8687/en
ME NewsWire/ Business Wire
PHILADELPHIA - Wednesday, October 2nd 2013
The Hay Group Global Life Sciences Practice has just released a proprietary white paper which asserts that a redoubled focus on “human capital”—how people are organized, managed and selected—can pay bigger dividends than usual for life sciences companies in today’s changing environment. Why? Partly because many of the usual avenues to success in the industry have been clogged or even cut off by circumstances ranging from the impact of the patent cliff to the new composition of the “market” and what it expects from the life sciences industry. But mainly because the “sea change” in the industry has destroyed the efficacy of the traditional business model. Companies that formerly operated in a very well known space have now been forced to enter uncharted waters.
In a series of releases to follow this white paper, Hay Group will introduce data from its various life sciences databases which expose issues that support the tremendous upside potential of a human capital focus—from a pattern of potentially innovation-stifling management “de-motivation” that is high to the “engagement gap” in R&D.
“With the industry needing a radical mindset change to cope with the new value-based, customer-focused environment, it can’t just resort to modest structural change and move the same bodies into the new boxes,” according to the Hay Group paper’s primary author, Ian Wilcox, Vice president and managing director, global life sciences.
“There are fewer and fewer skill sets and required competencies from “old pharma” that match the ones needed in “new pharma,“ Wilcox contends. What we are seeing now is that many companies have made progress in blowing up the old business model and even reorganizing their structures in service of a new strategy—but the people side has received less emphasis—and that’s what makes even routine, let alone radical change, succeed. Since in many areas of the business this will almost mean starting from scratch, those companies that get ahead of the human capital curve will have a distinct advantage over their competition.
View white paper and companion blog here—white paper includes commentary from William Looney, Editor of Pharmaceutical Executive; Dr. Tehseen Salimi, former vice president of global evidence and value development at Sanofi; and Thomas P. Ference, clinical professor of health policy and management at the Mailman School at Columbia University.
About Hay Group
Hay Group is a global management consulting firm that works with leaders to transform strategy into reality. We develop talent, organize people to be more effective and motivate them to perform at their best. Our focus is on making change happen and helping people and organizations realize their potential. Visit www.haygroup.com
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20131001007045/en/
Contacts
Hay Group
Doran Twer
Ph: +1-215-861-2337
C: +1-215-470-1800
doran.twer@haygroup.com
Permalink: http://www.me-newswire.net/news/8687/en
LG’s New G2 Smartphone Offers Big-Screen Viewing Options With its SlimPort Interface from Analogix Semiconductor
G2 Buyers Can Display HD Movies, Give Presentations or Play Video Games on Any Size Screen
SANTA CLARA, Calif. - Tuesday, October 1st 2013 [ME NewsWire]
(BUSINESS WIRE) LG’s new flagship smartphone, the G2, is now available at all major U.S. wireless carriers including Verizon Wireless, AT&T, T-Mobile and Sprint, as well as BestBuy. The G2 offers consumers some of the most advanced mobile features on the market today, and its built-in SlimPort™ interface makes life-on-the-go even better on a bigger screen.
Connecting easily with projectors – both HDMI and older VGA models – as well as with TVs and computer monitors, the SlimPort solution from Analogix Semiconductor enables G2 users to plug in their handset and give presentations or share movies on any size screen, either on the road, in the office or at home. G2s and other SlimPort-enabled devices can even function as mobile gaming system controllers.
“LG’s next-generation G2 smartphone was designed for how people truly want to use their devices,” said Dr. Ramchan Woo, LG’s smartphone platform division leader. “That’s why we chose to design in SlimPort connectivity, which will allow G2 users to display their movies, pictures and other content on a wide range of big-screen displays.”
“We’re pleased that LG has selected our SlimPort solution for its latest flagship smartphone, as well as for the G2’s predecessor, the Optimus G Pro,” said Andre Bouwer, vice president of marketing for Analogix. “SlimPort-enabled products are continuing to gain market traction as manufacturers and consumers alike recognize the advantages of a single high-performance interface that connects to multiple types of displays.”
Analogix Semiconductor is the leading supplier of DisplayPort-compliant semiconductors and IP products used in notebooks, tablets and other mobile devices. The DisplayPort standard is an innovative, packetized digital interface for high-resolution video and audio that was developed by the Video Electronics Standards Association (VESA). Analogix SlimPort products are based on DisplayPort technology.
About Analogix Semiconductor
Analogix Semiconductor, Inc. designs and manufactures semiconductors for the digital multimedia market, from portable devices such as smartphones to high-end graphics cards and large, high-definition displays. Analogix is the market leader in providing end-to-end interface connectivity semiconductor solutions for DisplayPort, including the SlimPort family of products. For more information visit www.analogix.com or follow us on Twitter @Analogix.
Analogix and SlimPort are trademarks or registered trademarks of Analogix Semiconductor, Inc. All other trademarks and trade names are the property of their respective owners.
Contacts
Analogix Media Contact
Jonelle Birney Sullivan, 415-819-0847
sullivanj@fullandby.co
Permalink: http://www.me-newswire.net/news/8676/en
SANTA CLARA, Calif. - Tuesday, October 1st 2013 [ME NewsWire]
(BUSINESS WIRE) LG’s new flagship smartphone, the G2, is now available at all major U.S. wireless carriers including Verizon Wireless, AT&T, T-Mobile and Sprint, as well as BestBuy. The G2 offers consumers some of the most advanced mobile features on the market today, and its built-in SlimPort™ interface makes life-on-the-go even better on a bigger screen.
Connecting easily with projectors – both HDMI and older VGA models – as well as with TVs and computer monitors, the SlimPort solution from Analogix Semiconductor enables G2 users to plug in their handset and give presentations or share movies on any size screen, either on the road, in the office or at home. G2s and other SlimPort-enabled devices can even function as mobile gaming system controllers.
“LG’s next-generation G2 smartphone was designed for how people truly want to use their devices,” said Dr. Ramchan Woo, LG’s smartphone platform division leader. “That’s why we chose to design in SlimPort connectivity, which will allow G2 users to display their movies, pictures and other content on a wide range of big-screen displays.”
“We’re pleased that LG has selected our SlimPort solution for its latest flagship smartphone, as well as for the G2’s predecessor, the Optimus G Pro,” said Andre Bouwer, vice president of marketing for Analogix. “SlimPort-enabled products are continuing to gain market traction as manufacturers and consumers alike recognize the advantages of a single high-performance interface that connects to multiple types of displays.”
Analogix Semiconductor is the leading supplier of DisplayPort-compliant semiconductors and IP products used in notebooks, tablets and other mobile devices. The DisplayPort standard is an innovative, packetized digital interface for high-resolution video and audio that was developed by the Video Electronics Standards Association (VESA). Analogix SlimPort products are based on DisplayPort technology.
About Analogix Semiconductor
Analogix Semiconductor, Inc. designs and manufactures semiconductors for the digital multimedia market, from portable devices such as smartphones to high-end graphics cards and large, high-definition displays. Analogix is the market leader in providing end-to-end interface connectivity semiconductor solutions for DisplayPort, including the SlimPort family of products. For more information visit www.analogix.com or follow us on Twitter @Analogix.
Analogix and SlimPort are trademarks or registered trademarks of Analogix Semiconductor, Inc. All other trademarks and trade names are the property of their respective owners.
Contacts
Analogix Media Contact
Jonelle Birney Sullivan, 415-819-0847
sullivanj@fullandby.co
Permalink: http://www.me-newswire.net/news/8676/en
MoI Receives Ideas UK’s Platinum Category for its Institutional Suggestions System
ABU DHABI, United Arab Emirates - Tuesday, October 1st 2013 [ME NewsWire]
Marking a new scientific milestone for work systems implemented to enhance an initiative spirit among its employees, the Ministry of Interior (MoI) has received the platinum certificate from Ideas UK. MoI is the first governmental ministry to receive the platinum certificate from the first assessment carried out by a team from the association.
The platinum category is the highest level within the Ideas UK classification, followed by gold then bronze categories.
The ministry received this credit after an auditing process performed by auditors from the association on the Institutional Suggestions System implemented by the Ministry of Interior via the Strategy and Performance Development Directorate General. The ministry utilizes the system to encourage employees to contribute with their recommendations and ideas, in order to improve performance and productivity, develop the working environment, and increase client satisfaction.
At the announcement of this win, Colonel Mohammed Hamid bin Dalmouj Al Dhaheri, Strategy and Performance Development Director General, the General Secretariat of the Office of H.H Deputy Prime Minister and Minister of Interior, said: “This success is a result of the instructions of Lt. General HH Sheikh Saif bin Zayed Al Nahyan, Deputy Prime Minister and Minister of Interior. It is in line with the vision of the Ministry of Interior to encourage us to work efficiently to make the United Arab Emirates one of the safest and most secure countries in the world by providing high quality police services to both citizens and residents. The quality of safety and security has become a global essential need and it is thus important for us to provide a safe life for everyone who lives in this country.”
He added: “The achievements of the Ministry of Interior, by receiving numerous excellence awards locally, regionally, and internationally truly reflects the level of development that it has attained. These achievements are attributed to the supervision and the support of the police leadership that closely and continuously follows up in order to improve governmental performance in general. Another factor for this success is the capabilities of the security forces and their distinct efficiency, as well as the complete belief in providing an intact and stable work environment and improving the services provided to the public.”
The auditing team expressed their extreme admiration for the systematic work process followed at the ministry; the efforts of the team entrusted to supervise the suggestions system; and the future development plans whether on work procedures or the e-system, which has enhanced the concept of communication among all employees.
The platinum category is awarded if the suggestion system efficiency achieves 90% or more, according to the Ideas UK standards; the standards include 86 standards covering all legal and financial aspects, the system procedures and regulations, the system feasibility and connection to the institution’s organizational chart. The criteria also check if the system is able to achieve the goals of the institution. It also looks into the communications and publications (awareness aspects), incentives and bonuses, performance indicators, system efficiency, information management, employee training, and ways of developing the training programs.
Ideas UK is a non-profit association that supports and enhances employee initiatives around the world using modern methodologies. It provides the means to exchange knowledge and expertise among different governmental and private institutions from around the globe. Dubai Customs is a member of Ideas UK; the Employee Involvement Association, a US association dedicated to suggestions, ideas and participation of employees; and Ideas Arabia Association.
For more information about:
The Ministry of Interior, please click HERE
Abu Dhabi Police, please click HERE
Follow us and check our Social Media feeds on: YouTube, Facebook and Twitter
Photo Captions:
Photo 1: Colonel Mohammed Hamid bin Dalmouj
The Arabic-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the Arabic-language text, which is the only version of the text intended to have legal effect.
Contacts
The UAE Minister of Interior's General Secretariat, Tactical Affairs and Security Media Department
Abu Dhabi Police GHQ - Security Media
Chris Cron +971-(0)-50-987-1317
E-mail: cron.media@hotmail.com
Marking a new scientific milestone for work systems implemented to enhance an initiative spirit among its employees, the Ministry of Interior (MoI) has received the platinum certificate from Ideas UK. MoI is the first governmental ministry to receive the platinum certificate from the first assessment carried out by a team from the association.
The platinum category is the highest level within the Ideas UK classification, followed by gold then bronze categories.
The ministry received this credit after an auditing process performed by auditors from the association on the Institutional Suggestions System implemented by the Ministry of Interior via the Strategy and Performance Development Directorate General. The ministry utilizes the system to encourage employees to contribute with their recommendations and ideas, in order to improve performance and productivity, develop the working environment, and increase client satisfaction.
At the announcement of this win, Colonel Mohammed Hamid bin Dalmouj Al Dhaheri, Strategy and Performance Development Director General, the General Secretariat of the Office of H.H Deputy Prime Minister and Minister of Interior, said: “This success is a result of the instructions of Lt. General HH Sheikh Saif bin Zayed Al Nahyan, Deputy Prime Minister and Minister of Interior. It is in line with the vision of the Ministry of Interior to encourage us to work efficiently to make the United Arab Emirates one of the safest and most secure countries in the world by providing high quality police services to both citizens and residents. The quality of safety and security has become a global essential need and it is thus important for us to provide a safe life for everyone who lives in this country.”
He added: “The achievements of the Ministry of Interior, by receiving numerous excellence awards locally, regionally, and internationally truly reflects the level of development that it has attained. These achievements are attributed to the supervision and the support of the police leadership that closely and continuously follows up in order to improve governmental performance in general. Another factor for this success is the capabilities of the security forces and their distinct efficiency, as well as the complete belief in providing an intact and stable work environment and improving the services provided to the public.”
The auditing team expressed their extreme admiration for the systematic work process followed at the ministry; the efforts of the team entrusted to supervise the suggestions system; and the future development plans whether on work procedures or the e-system, which has enhanced the concept of communication among all employees.
The platinum category is awarded if the suggestion system efficiency achieves 90% or more, according to the Ideas UK standards; the standards include 86 standards covering all legal and financial aspects, the system procedures and regulations, the system feasibility and connection to the institution’s organizational chart. The criteria also check if the system is able to achieve the goals of the institution. It also looks into the communications and publications (awareness aspects), incentives and bonuses, performance indicators, system efficiency, information management, employee training, and ways of developing the training programs.
Ideas UK is a non-profit association that supports and enhances employee initiatives around the world using modern methodologies. It provides the means to exchange knowledge and expertise among different governmental and private institutions from around the globe. Dubai Customs is a member of Ideas UK; the Employee Involvement Association, a US association dedicated to suggestions, ideas and participation of employees; and Ideas Arabia Association.
For more information about:
The Ministry of Interior, please click HERE
Abu Dhabi Police, please click HERE
Follow us and check our Social Media feeds on: YouTube, Facebook and Twitter
Photo Captions:
Photo 1: Colonel Mohammed Hamid bin Dalmouj
The Arabic-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the Arabic-language text, which is the only version of the text intended to have legal effect.
Contacts
The UAE Minister of Interior's General Secretariat, Tactical Affairs and Security Media Department
Abu Dhabi Police GHQ - Security Media
Chris Cron +971-(0)-50-987-1317
E-mail: cron.media@hotmail.com
Subscribe to:
Posts (Atom)